Table 1. Clinical and laboratory summary... | Rockefeller University Press

Table 1.

Clinical and laboratory summary of the FILS patients

Parameter	Patient ID
	V-1	VI-3	VI-9	VI-10	VI-11	VI-12	VI-28	VI-29	VI-31	VI-36	VI-38	VI-39	VII-1	VII-2
Gender	m	f	m	m	m	f	f	m	m	f	f	m	m	f
Age at last follow up (yr)	17	23	25	24	33	31	3	11	17	10	8	6	11	6
Recurrent respiratory infections	+	+	+	+	−	+	+	+	+	+	−	+	+	+
Facial dysmorphy	+	+	+	+	+	+	+	−	+	+	+	+	+	+
Livedo	+	+	+	+	+	+	+	−	+	+	+	+	+	+
Bone disease	−	+	−	−	+	−	−	+	−	−	−	−	−	−
Short stature	(+)	+	−	+	+	++	++	(+)	(+)	+	nd	(+)	++	(+)
IgM	↓	↓	nd	↓	↓	↓	↓	↓	↓	↓	↓	↓	↓	↓
Anti–S. pneumoniae polysaccharide IgG	↓	nd	nd	nd	nd	nd	↓	nd	↓	↓	↓	↓	↓	↓

Parameter	Patient ID
	V-1	VI-3	VI-9	VI-10	VI-11	VI-12	VI-28	VI-29	VI-31	VI-36	VI-38	VI-39	VII-1	VII-2
Gender	m	f	m	m	m	f	f	m	m	f	f	m	m	f
Age at last follow up (yr)	17	23	25	24	33	31	3	11	17	10	8	6	11	6
Recurrent respiratory infections	+	+	+	+	−	+	+	+	+	+	−	+	+	+
Facial dysmorphy	+	+	+	+	+	+	+	−	+	+	+	+	+	+
Livedo	+	+	+	+	+	+	+	−	+	+	+	+	+	+
Bone disease	−	+	−	−	+	−	−	+	−	−	−	−	−	−
Short stature	(+)	+	−	+	+	++	++	(+)	(+)	+	nd	(+)	++	(+)
IgM	↓	↓	nd	↓	↓	↓	↓	↓	↓	↓	↓	↓	↓	↓
Anti–S. pneumoniae polysaccharide IgG	↓	nd	nd	nd	nd	nd	↓	nd	↓	↓	↓	↓	↓	↓

f, female; m, male; nd, not done. For Short stature, “+” indicates less than −2 SD; “(+)” indicates −2 SD; and “++” indicates −4 SD or less. For IgM, ”↓” indicates below −2 SD. For Anti–S. pneumoniae polysaccharide IgG, ”↓” indicates antibody titer increase after nonconjugate anti-pneumococcal 23-valent vaccine less than fourfold.

[ViewLarge]